IRB Advisor – April 1, 2009
April 1, 2009
View Issues
-
With state university budget cuts it might be time to cut IRB costs
IRBs across the nation are bracing for budget cuts as states slice funding to higher education and the recession's impact is felt by IRBs and research institutions. -
Some suggestions to make your IRB fiscally fit
As IRBs face budget cuts, they can make some improvements in their processes that will make them more cost efficient. -
Special Report: IRBs need to become better at collecting outcomes, costs data
In lean times, IRBs will have to become more disciplined. And part of their discipline will need to include collecting data about their own efficiency, outcomes, and cost-effectiveness, an expert says. -
Ask2-4U: Informed consent is an ongoing job
Tracy Arwood, MS, director of research compliance at Clemson University's office of research compliance in Clemson, SC, has dealt with a variety of consent issues over the years, including handling informed consent of college students and from community leaders. She offers this advice about how to improve the informed consent process to IRB Advisor readers: -
IND monitoring program wins protection award
An innovative program at M.D. Anderson Cancer Center in Houston, TX, provides continuous oversight of investigational new drug (IND) trials over the life of a trial, using a monitoring services office created expressly for that purpose. -
Views differ on HIV research in the developing world
IRBs in the United States and research ethics committees (RECs) in the developing world who review HIV vaccine trials must struggle with a number of tough ethical issues ensuring adequate, culturally sensitive informed consent, protecting privacy, determining the standard of treatment for participants who become infected with HIV during a trial. -
Giving informed consent to biobank participants
As IRBs review the rollout of new biobanks, they need to ensure that people who agree to participate in them truly understand what that means. -
Cancer: It takes a community
Several institutions have received grants to implement their ideas for engaging the community in cancer clinical trials.